- About Overview
- Diversity, Equity, and Inclusion
- Honors and Awards
- Facts and Figures
- Support the School
- Contact Us
- Organization Overview
- Dean’s Office
- Dean’s Office Overview
- PharmD Education Unit
- Office of Faculty Academic Affairs
- Office of Administration
- Pharmacy Practice Partnerships
- Department of Bioengineering and Therapeutic Sciences
- Department of Clinical Pharmacy
- Department of Pharmaceutical Chemistry
- Quantitative Biosciences Institute
- Org Chart
- Patient Care
Consortium inventing medical devices for children gets new funding
By UCSF School of Pharmacy Editorial Staff / Thu Nov 10, 2011
A two-year-old, cross-disciplinary effort to invent new medical devices for children, co-founded by bioengineer Shuvo Roy, PhD, has received a two-year $1 million grant from the U.S. Food and Drug Administration (FDA) to expand its work.
The Pediatric Device Consortium, first funded in 2009, has already developed a device that uses magnets and minor surgery to correct the congenital deformity called sunken chest. The Magnetic Mini-Mover, now in clinical trials, could replace major surgery. Other devices for early onset scoliosis and gastrointestinal anomalies are in preclinical phases.
Co-led by Roy, a faculty member in the Department of Bioengineering and Therapeutic Sciences, a joint department of the UCSF Schools of Pharmacy and Medicine, and Michael Harrison, MD, director emeritus and co-founder of the Fetal Treatment Center at UCSF Benioff Children's Hospital, the consortium holds twice-weekly “think tank” sessions on the Parnassus and Mission Bay campuses that bring together engineers, clinicians, and innovators from UCSF and industry to discuss new devices under development and brainstorm new ideas.
More: UCSF Consortium Collaborates to Invent Medical Devices for Children
School of Pharmacy, Department of Bioengineering and Therapeutic Sciences, PharmD Degree Program, QBC, PSPG, Biophysics
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.